Solutions

From strategy to patient impact

Tarseva connects portfolio intelligence, execution discipline, and lifecycle expertise into integrated solutions built around the outcomes that matter most to your organization.

Capabilities working together

Most life sciences challenges don't fit neatly into a single capability. A portfolio prioritization effort surfaces execution gaps. A clinical program review reveals lifecycle strategy questions. A technology transformation exposes decision-making weaknesses that no tool can fix.

Tarseva is designed for this reality. Our four capabilities are distinct enough to address specific needs, and integrated enough to work together when the challenge demands it. The solutions below describe how we combine them to address the most common cross-cutting challenges our clients face.

Portfolio & pipeline

Pipeline prioritization and capital allocation

The challenge

Leadership needs to make defensible investment decisions across a complex pipeline — but lacks the analytical infrastructure to evaluate programs on a consistent basis, model trade-offs, or communicate the rationale to boards and investors.

Our approach

We build the decision frameworks, scoring models, and portfolio visualization tools that make prioritization rigorous and repeatable. Then we embed them in the governance processes that ensure decisions are actually made — and revisited when the data changes.

Relevant industries

PharmaceuticalsBiotechnology
Discuss this solution
Lifecycle strategy

Patent cliff and lifecycle extension

The challenge

A key asset is approaching loss of exclusivity. The organization needs to identify and evaluate lifecycle extension options — new indications, reformulations, combination strategies — and build a credible plan before the window closes.

Our approach

We combine scientific and commercial assessment of extension options with the portfolio analytics to evaluate them against the broader pipeline. The result is a prioritized lifecycle strategy with a clear development and regulatory pathway.

Execution transformation

PMO design and enterprise execution capability

The challenge

The organization has a strategy. It has programs. What it lacks is the execution infrastructure — governance, program management capability, reporting, and accountability — to translate strategy into consistent outcomes.

Our approach

We design and stand up the PMO structures, governance frameworks, and program management practices that give organizations the execution capability they need. We work alongside internal teams to build capability, not just deliver a report.

Relevant industries

PharmaceuticalsBiotechnologyCROs & CDMOs
Discuss this solution
Clinical & regulatory

Clinical program management and regulatory coordination

The challenge

A complex clinical program is running across multiple sites, functions, and geographies. The organization needs experienced program management to keep it on track — and the regulatory coordination to ensure the development plan supports the target label.

Our approach

We provide the program management infrastructure and regulatory strategy expertise to manage complex clinical programs from IND through NDA/BLA. Our teams work as an extension of the sponsor organization, not as a CRO.

Relevant industries

PharmaceuticalsBiotechnologyMedical Devices
Discuss this solution

Not sure which solution fits your challenge?

Most engagements start with a conversation. Tell us what you're working on and we'll tell you how we can help.